Alseroxylon

Alseroxylon (Rautensin, Rauwiloid) is a norepinephrine reuptake inhibitor that has been investigated in the treatment of hypertension[1] and angina pectoris and as a sedative in psychoses.[2] It was at one time approved for use in the United States, but has since been discontinued.[3]

Alseroxylon
Reserpine, the major component of alseroxylon
Clinical data
ATC code
Identifiers
CAS Number
DrugBank
ChemSpider
  • None
UNII
ChEMBL
Chemical and physical data
FormulaVaries
 NY (what is this?)  (verify)

Alseroxylon is a purified fat-soluble extract of the root of Rauvolfia serpentina, containing reserpine and other nonadrenolytic amorphous alkaloids.[2]

References

  1. Green RS, Davolos D (May 1956). "A long-term study of the effect of crude Rauwolfia serpentina and of its alseroxylon fraction in patients with hypertension". The American Journal of Medicine. 20 (5): 760–73. doi:10.1016/0002-9343(56)90158-9. PMID 13313574.
  2. DrugBank DB00386
  3. Approved Drug Products with Therapeutic Equivalence Evaluations. FDA Orange Book (33rd ed.). 2013.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.